| Cat. No. |
Product Name |
Effect
|
Purity |
Rare Diseases
|
| HY-13433 |
Thapsigargin |
|
99.95% |
Unkown |
| HY-18234A |
Leupeptin hemisulfate |
Inhibitor |
99.39% |
Yes |
| HY-14393 |
Emodin |
Inhibitor |
99.25% |
Yes |
| HY-D0837 |
Imidazole |
Inhibitor |
99.96% |
Unkown |
| HY-108477 |
TMPyP4 tosylate |
Inhibitor |
98.0% |
Unkown |
| HY-160412 |
Balinatunfib |
Inhibitor |
99.94% |
Unkown |
| HY-N1913 |
Danshensu |
|
99.90% |
Unkown |
| HY-15458 |
SAR131675 |
Inhibitor |
99.85% |
Unkown |
| HY-W013151 |
1-Pyrenebutyric acid N-hydroxysuccinimide ester |
Chemical |
99.93% |
Unkown |
| HY-146246 |
EIDD-2749 |
Inhibitor |
99.86% |
Unkown |
| HY-100575 |
Acriflavine |
Inhibitor |
98.0% |
Unkown |
| HY-100211 |
TAPI-2 |
Inhibitor |
97.41% |
Unkown |
| HY-138794 |
XL177A |
Inhibitor |
99.60% |
Unkown |
| HY-110066 |
(Z)-Guggulsterone |
|
99.41% |
Unkown |
| HY-N7378 |
N-Hydroxypipecolic acid |
|
≥98.0% |
Unkown |
| HY-138113 |
Pyrrothiogatain |
Inhibitor |
98.61% |
Unkown |
| HY-117043 |
GRL0617 |
Inhibitor |
99.62% |
Unkown |
| HY-10929 |
UNC0224 |
Inhibitor |
98.93% |
Unkown |
| HY-119293 |
K777 |
Inhibitor |
99.14% |
Unkown |
| HY-155876 |
NVP-DFV890 |
Antagonist |
99.97% |
Unkown |
| HY-15699 |
SAR7334 |
Inhibitor |
99.21% |
Unkown |
| HY-152955 |
STING agonist-22 |
Agonist |
99.83% |
Unkown |
| HY-101984 |
N6,N6-Dimethyladenosine |
|
99.66% |
Unkown |
| HY-W010276 |
H-Gly-Sar-OH |
|
99.87% |
Unkown |
| HY-N1996 |
Chebulagic acid |
Inhibitor |
99.85% |
Unkown |
| HY-146248B |
TFMU-ADPr diammonium |
|
98.78% |
Unkown |
| HY-P3042 |
Chymostatin |
Inhibitor |
99.9% |
Unkown |
| HY-120852 |
JG26 |
|
98.14% |
Unkown |
| HY-17589R |
Chloroquine phosphate (Standard) |
Inhibitor |
99.67% |
Unkown |
| HY-B1513 |
α-Cyclodextrin |
Inhibitor |
99.96% |
Unkown |
| HY-117626 |
LP-935509 |
Inhibitor |
99.74% |
Unkown |
| HY-N2183 |
Baimaside |
Inhibitor |
99.57% |
Unkown |
| HY-N3415 |
Kumatakenin |
|
99.31% |
Unkown |
| HY-W012531 |
2-Hydroxycinnamic acid |
Inhibitor |
99.86% |
Unkown |
| HY-N1951 |
Miltirone |
|
99.54% |
Unkown |
| HY-N2116 |
Ginkgolic acid C17:1 |
|
99.80% |
Unkown |
| HY-P11146 |
SppIP |
Inhibitor |
98.99% |
Unkown |
| HY-117813 |
2-Thiouridine |
Inhibitor |
99.92% |
Unkown |
| HY-W011342 |
Fmoc-Sar-OH |
|
99.93% |
Unkown |
| HY-108137 |
Z-LVG-CHN2 |
Inhibitor |
99.88% |
Unkown |
| HY-N2014 |
Verbenalin |
Inhibitor |
99.93% |
Unkown |
| HY-10930 |
UNC0321 |
Inhibitor |
99.91% |
Unkown |
| HY-G0017 |
N-Desmethyl imatinib |
|
98.33% |
Unkown |
| HY-N0713 |
Diosmetin-7-O-β-D-glucopyranoside |
Inhibitor |
99.61% |
Unkown |
| HY-P5522A |
TriDAP dihydrochloride |
|
99.16% |
Unkown |
| HY-113478S |
Ursodeoxycholic acid-d4 |
|
99.52% |
Unkown |
| HY-W016887 |
Glycyl-L-proline |
Inducer |
99.88% |
Unkown |
| HY-N3266 |
Methyl rosmarinate |
|
99.89% |
Unkown |
| HY-100895 |
SAR-20347 |
Inhibitor |
97.27% |
Unkown |
| HY-15699A |
SAR7334 hydrochloride |
Inhibitor |
96.04% |
Unkown |
| HY-143216A |
Ensitrelvir fumarate |
Inhibitor |
99.94% |
Unkown |
| HY-108511 |
PB28 dihydrochloride |
|
99.63% |
Unkown |
| HY-126085 |
(±)-Alliin |
Inhibitor |
98.21% |
Unkown |
| HY-132280 |
Tirilazad |
Inhibitor |
98.11% |
Unkown |
| HY-152956 |
STING agonist-23 |
Agonist |
99.33% |
Unkown |
| HY-N0891 |
Tubeimoside II |
|
99.90% |
Unkown |
| HY-W015230 |
Boc-Sar-OH |
|
98.0% |
Unkown |
| HY-150737 |
MI-1851 |
Inhibitor |
95.92% |
Unkown |
| HY-18219 |
Walrycin B |
Inhibitor |
98.11% |
Unkown |
| HY-B1370R |
Hydroxychloroquine sulfate (Standard) |
Inhibitor |
99.96% |
Unkown |
| HY-N2016 |
Arteannuin B |
|
99.89% |
Unkown |
| HY-137048 |
PF-00835231 |
Inhibitor |
99.31% |
Unkown |
| HY-13807 |
UNC0646 |
Inhibitor |
99.38% |
Unkown |
| HY-148072 |
MM3122 |
Inhibitor |
99.20% |
Unkown |
| HY-159700 |
AA3-DLin |
|
99.0% |
Unkown |
| HY-W028142 |
Quipazine |
|
97.0% |
Unkown |
| HY-153879 |
C12-TLRa |
Ligand |
99.0% |
Unkown |
| HY-12473 |
Vps34-IN-2 |
Inhibitor |
99.81% |
Unkown |
| HY-108986 |
JFD00244 |
Inhibitor |
99.40% |
Unkown |
| HY-157403 |
Jun12682 |
Inhibitor |
99.60% |
Unkown |
| HY-173521 |
JNJ-9676 |
Inhibitor |
99.74% |
Unkown |
| HY-N0886 |
Aloin B |
Inhibitor |
99.87% |
Unkown |
| HY-N3389 |
Licoisoflavone A |
|
99.53% |
Unkown |
| HY-108494 |
CYM50260 |
Agonist |
98.94% |
Unkown |
| HY-124564 |
Methisazone |
Inhibitor |
99.37% |
Unkown |
| HY-153235 |
COVID-19 Spike Protein mRNA-LNP |
|
/ |
Unkown |
| HY-15458A |
(S)-SAR131675 |
Inhibitor |
99.72% |
Unkown |
| HY-17542 |
PLpro inhibitor |
Inhibitor |
99.88% |
Unkown |
| HY-12648A |
FASN-IN-4 tosylate |
Inhibitor |
98.55% |
Unkown |
| HY-100749 |
HeE1-2Tyr |
Inhibitor |
96.68% |
Unkown |
| HY-149535 |
Iscartrelvir |
Inhibitor |
99.91% |
Unkown |
| HY-172760 |
CIM-834 |
Inhibitor |
99.14% |
Unkown |
| HY-P1012 |
[Sar9,Met(O2)11]-Substance P |
Agonist |
99.60% |
Unkown |
| HY-P4685 |
(Sar1,Ile4,8)-Angiotensin II |
Agonist |
98.23% |
Unkown |
| HY-W195509 |
Debrisoquin hydroiodide |
Inhibitor |
99.84% |
Unkown |
| HY-109037S3 |
Mavacamten-d5 |
Modulator |
98.01% |
Unkown |
| HY-108447 |
BC-11 hydrobromide |
Inhibitor |
99.22% |
Unkown |
| HY-135909 |
TH1217 |
Modulator |
99.20% |
Unkown |
| HY-153894 |
SRX3177 |
|
99.33% |
Unkown |
| HY-161619 |
RMC-113 |
|
99.54% |
Unkown |
| HY-171160 |
WYFA-15 |
Inhibitor |
98.77% |
Unkown |
| HY-N1739 |
Tectoquinone |
Inhibitor |
98.40% |
Unkown |
| HY-W018062 |
H-Sar-OtBu.HCl |
|
98.0% |
Unkown |
| HY-153083 |
COVID-19 Spike Protein mRNA(N1-Me-Pseudo UTP) |
Inhibitor |
89% |
Unkown |
| HY-136303 |
GS-704277 |
|
98.77% |
Unkown |
| HY-137472 |
SAR502250 |
Inhibitor |
99.29% |
Unkown |
| HY-N1913A |
Danshensu sodium |
|
99.9% |
Unkown |
| HY-100195 |
SAR-020106 |
Inhibitor |
98.04% |
Unkown |
| HY-107735 |
CYM 9484 |
Antagonist |
98.68% |
Unkown |
| HY-118922 |
IW927 |
Inhibitor |
99.23% |
Unkown |
| HY-145119S |
Mindeudesivir |
|
98.20% |
Unkown |
| HY-155813 |
MPI60 |
Inhibitor |
98.35% |
Unkown |
| HY-156597 |
Arbemnifosbuvir |
Inhibitor |
99.40% |
Unkown |
| HY-W013517 |
Z-Sar-OH |
|
99.69% |
Unkown |
| HY-145119 |
GS-621763 |
Inhibitor |
99.72% |
Unkown |
| HY-103291 |
Sar-[D-Phe8]-des-Arg9-Bradykinin |
Agonist |
99.96% |
Unkown |
| HY-107577 |
Gedunin |
Inhibitor |
99.59% |
Unkown |
| HY-118653 |
SAR629 |
|
99.93% |
Unkown |
| HY-139165A |
AT-9010 tetrasodium |
Inhibitor |
99.88% |
Unkown |
| HY-14393R |
Emodin (Standard) |
Inhibitor |
98.84% |
Unkown |
| HY-152959 |
STING agonist-26 |
Agonist |
99.56% |
Unkown |
| HY-147020 |
Coronastat |
Inhibitor |
98.0% |
Unkown |
| HY-136149 |
Mpro inhibitor N3 |
Inhibitor |
99.76% |
Unkown |
| HY-150062 |
SARS-CoV-2 nsp3-IN-1 |
Inhibitor |
≥98.0% |
Unkown |
| HY-151482 |
SARS-CoV-2 Mpro-IN-2 |
Inhibitor |
98.96% |
Unkown |
| HY-155488 |
SHEN26 |
|
99.25% |
Unkown |
| HY-161177 |
PROTAC SARS-CoV-2 3CLPro degrader 2 |
Degrader |
98.59% |
Unkown |
| HY-161356 |
BPR3P0128 |
Inhibitor |
98.58% |
Unkown |
| HY-162675 |
COB-187 |
Inhibitor |
95.0% |
Unkown |
| HY-168034 |
diABZI-4 |
|
98.33% |
Unkown |
| HY-169092 |
PF-07957472 |
Inhibitor |
99.13% |
Unkown |
| HY-17042S1 |
Cetirizine-d8 |
Antagonist |
96.46% |
Unkown |
| HY-19727A |
FOY 251 |
Inhibitor |
98.86% |
Unkown |
| HY-44358 |
Remdesivir nucleoside monophosphate |
Inhibitor |
99.87% |
Unkown |
| HY-G0017S |
N-Desmethyl imatinib-d8 |
|
99.95% |
Unkown |
| HY-N8599 |
Cichoriin |
|
99.9% |
Unkown |
| HY-W024485 |
SARS-CoV-2-IN-86 |
Inhibitor |
99.35% |
Unkown |
| HY-163943 |
UNI418 |
Inhibitor |
99.61% |
Unkown |
| HY-12481A |
SAR405 R enantiomer |
Control |
99.94% |
Unkown |
| HY-136149A |
Mpro inhibitor N3 hemihydrate |
Inhibitor |
99.86% |
Unkown |
| HY-17589AS |
Chloroquine-d5 |
Inhibitor |
99.90% |
Unkown |
| HY-135853S |
Molnupiravir-d7 |
Inhibitor |
99.86% |
Unkown |
| HY-132808 |
Atuzabrutinib |
Inhibitor |
98.00% |
Unkown |
| HY-138067 |
SSAA09E2 |
Inhibitor |
98.37% |
Unkown |
| HY-101046 |
Quipazine dimaleate |
|
99.96% |
Unkown |
| HY-124304 |
Pinokalant |
Inhibitor |
99.09% |
Unkown |
| HY-136298A |
X77 |
Inhibitor |
99.95% |
Unkown |
| HY-137954 |
GRL-0496 |
Inhibitor |
99.20% |
Unkown |
| HY-137984 |
Cnicin |
|
99.14% |
Unkown |
| HY-139442 |
RdRP-IN-2 |
Inhibitor |
98.01% |
Unkown |
| HY-144770 |
SARS-CoV-2-IN-13 |
Inhibitor |
98.53% |
Unkown |
| HY-149264 |
SARS-CoV-2 3CLpro-IN-13 |
Inhibitor |
99.0% |
Unkown |
| HY-152101 |
LY1 |
Inhibitor |
98.01% |
Unkown |
| HY-P3801 |
[Glp5,(Me)Phe8,Sar9] Substance P (5-11) |
Modulator |
99.61% |
Unkown |
| HY-P4198 |
Fmoc-N(Me)-Sar10 |
|
98.22% |
Unkown |
| HY-P4388 |
Z-Arg-Leu-Arg-Gly-Gly-AMC |
|
99.93% |
Unkown |
| HY-113752 |
MMV019313 |
Inhibitor |
99.54% |
Unkown |
| HY-160554 |
C12-113 |
|
98.67% |
Unkown |
| HY-P4388A |
Z-Arg-Leu-Arg-Gly-Gly-AMC acetate |
|
98.85% |
Unkown |
| HY-W196368 |
Thymohydroquinone |
Inhibitor |
99.91% |
Unkown |
| HY-132306 |
CCF0058981 |
Inhibitor |
98.02% |
Unkown |
| HY-139582 |
Simpinicline |
|
99.45% |
Unkown |
| HY-104077S1 |
Remdesivir-d4 |
Inhibitor |
99.53% |
Unkown |
| HY-126419 |
Kobophenol A |
Inhibitor |
99.90% |
Unkown |
| HY-138102 |
SSAA09E3 |
Inhibitor |
99.42% |
Unkown |
| HY-138794A |
(Rac)-XL177A |
Inhibitor |
/ |
Unkown |
| HY-149408 |
MAOA-IN-1 |
Inhibitor |
98.24% |
Unkown |
| HY-149606 |
TKB245 |
Inhibitor |
98.98% |
Unkown |
| HY-149954 |
SARS-CoV-2-IN-39 |
Inhibitor |
99.79% |
Unkown |
| HY-150784 |
XR8-89 |
Inhibitor |
97.13% |
Unkown |
| HY-153377 |
Lipid 14 |
|
95.0% |
Unkown |
| HY-153533A |
GRL-1720 TFA |
Inhibitor |
98.94% |
Unkown |
| HY-155144 |
CDD-1845 |
Inhibitor |
99.60% |
Unkown |
| HY-158405 |
PAV-104 |
Inhibitor |
99.83% |
Unkown |
| HY-164166 |
Fmoc-Sar-Sar-Sar-OH |
|
98.45% |
Unkown |
| HY-17042S |
Cetirizine-d4 |
Antagonist |
99.10% |
Unkown |
| HY-D1270 |
Direct Violet 1 |
Inhibitor |
/ |
Unkown |
| HY-N1910 |
4'-O-Methylbavachalcone |
Inhibitor |
99.64% |
Unkown |
| HY-P1738 |
[Sar9] Substance P |
Agonist |
98.14% |
Unkown |
| HY-P2381 |
Sar-Arg-Val-Tyr-Val-His-NH2 |
Agonist |
96.63% |
Unkown |
| HY-P3138 |
(Sar1)-Angiotensin II |
Agonist |
99.84% |
Unkown |
| HY-144800 |
FWM-1 |
Inhibitor |
95.0% |
Unkown |
| HY-155280 |
SARS-CoV-2-IN-60 |
Inhibitor |
99.22% |
Unkown |
| HY-157154 |
MAT-POS-e194df51-1 |
Inhibitor |
98.45% |
Unkown |
| HY-N8671 |
Withanoside V |
Inhibitor |
99.9% |
Unkown |
| HY-P5168S |
GPSVFPLAPSSK-13C6,15N2 |
Inhibitor |
98.62% |
Unkown |
| HY-W004812 |
BOC-(1R,3S)-3-aminocyclopentane carboxylic acid |
Inhibitor |
98.0% |
Unkown |
| HY-W1116287 |
N-Acetyl-Sar24 |
|
97.02% |
Unkown |
| HY-104077S |
Remdesivir-d5 |
Inhibitor |
99.86% |
Unkown |
| HY-164485 |
INI-4001 |
|
/ |
Unkown |
| HY-12481 |
SAR405 |
Inhibitor |
99.74% |
Unkown |
| HY-12648 |
FASN-IN-4 |
Inhibitor |
99.21% |
Unkown |
| HY-135855 |
SARS-CoV-IN-1 |
Inhibitor |
99.88% |
Unkown |
| HY-135856 |
SARS-CoV-IN-2 |
Inhibitor |
98.66% |
Unkown |
| HY-135858 |
SARS-CoV-IN-3 |
Inhibitor |
99.36% |
Unkown |
| HY-136259 |
ML188 |
Inhibitor |
99.87% |
Unkown |
| HY-13247 |
Setrobuvir |
Inhibitor |
99.98% |
Unkown |
| HY-136298 |
(Rac)-X77 |
Inhibitor |
99.65% |
Unkown |
| HY-139311 |
YH-53 |
Inhibitor |
98.78% |
Unkown |
| HY-W031727S |
Hydroxychloroquine-d4-1 sulfate |
Inhibitor |
≥98.0% |
Unkown |
| HY-100442S1 |
Paquinimod-d5-1 |
Inhibitor |
98.19% |
Unkown |
| HY-119980S |
Fluphenazine-d8 |
|
99.12% |
Unkown |
| HY-125729 |
Ivermectin B1b |
Inhibitor |
98.66% |
Unkown |
| HY-129116 |
SSAA09E1 |
Inhibitor |
99.54% |
Unkown |
| HY-132886 |
SARS-CoV-2-IN-6 |
Inhibitor |
99.94% |
Unkown |
| HY-136284 |
XP-59 |
Inhibitor |
99.67% |
Unkown |
| HY-136597 |
Remdesivir O-desphosphate acetonide impurity |
Inhibitor |
99.88% |
Unkown |
| HY-139165B |
AT-9010 triethylamine |
Inhibitor |
/ |
Unkown |
| HY-139683 |
Antiviral agent 5 |
Chemical |
98.93% |
Unkown |
| HY-139908 |
MERS-CoV-IN-1 |
Inhibitor |
99.53% |
Unkown |
| HY-141841 |
SARS-CoV-2-IN-7 |
Inhibitor |
98.84% |
Unkown |
| HY-144771 |
SARS-CoV-2-IN-14 |
Inhibitor |
99.02% |
Unkown |
| HY-144772 |
SARS-CoV-2-IN-15 |
Inhibitor |
99.65% |
Unkown |
| HY-146248A |
TFMU-ADPr triethylamine |
|
97.26% |
Unkown |
| HY-146998 |
SARS-CoV-2 3CLpro-IN-2 |
Inhibitor |
99.71% |
Unkown |
| HY-149321 |
SARS-CoV-2 nsp14-IN-3 |
Inhibitor |
≥95.0% |
Unkown |
| HY-150622 |
SARS-CoV-2 nsp13-IN-1 |
Inhibitor |
99.91% |
Unkown |
| HY-153533 |
GRL-1720 |
Inhibitor |
98.87% |
Unkown |
| HY-15463S2 |
Imatinib-d3 hydrochloride |
|
95.19% |
Unkown |
| HY-157778 |
MK-7845 |
Inhibitor |
/ |
Unkown |
| HY-158763A |
MPI8 TFA |
Inhibitor |
/ |
Unkown |
| HY-162484 |
GZNL-P36 |
Inhibitor |
98.97% |
Unkown |
| HY-168457 |
RNase L ligand 2 |
|
/ |
Unkown |
| HY-170524 |
TDI-015051 |
Inhibitor |
/ |
Unkown |
| HY-175029 |
ALG-097558 |
Inhibitor |
/ |
Unkown |
| HY-17589S1 |
Chloroquine-d4 phosphate |
Inhibitor |
98.01% |
Unkown |
| HY-179630 |
MS102 |
Inhibitor |
/ |
Unkown |
| HY-19727 |
FOY 251 free base |
Inhibitor |
/ |
Unkown |
| HY-B0372AS |
Bromhexine-d3 hydrochloride |
|
99.0% |
Unkown |
| HY-B1028S |
Pantethine-15N2 |
|
/ |
Unkown |
| HY-N10109A |
Gallinamide A TFA |
Inhibitor |
99.85% |
Unkown |
| HY-N10871 |
Neocryptomerin |
Inhibitor |
99.14% |
Unkown |
| HY-N11722 |
Panduratin A |
|
99.9% |
Unkown |
| HY-N11902 |
1,7-Bis(4-hydroxyphenyl)-1,4,6-heptatrien-3-one |
Inhibitor |
95.51% |
Unkown |
| HY-N12110 |
SMU-CX1 |
Inhibitor |
99.9% |
Unkown |
| HY-N12697A |
Polycarpine hydrochloride |
Inhibitor |
98.05% |
Unkown |
| HY-N2949 |
Bonducellpin D |
Inhibitor |
98.0% |
Unkown |
| HY-N8306 |
Isojacareubin |
|
98.0% |
Unkown |
| HY-N9351 |
Cleistanthin B |
Inhibitor |
98.19% |
Unkown |
| HY-P1012A |
[Sar9,Met(O2)11]-Substance P TFA |
Agonist |
98.58% |
Unkown |
| HY-P11032 |
Mp-4D7-pF2 |
Inhibitor |
/ |
Unkown |
| HY-P5407A |
HD5 TFA |
Inhibitor |
95.30% |
Unkown |
| HY-P5642A |
Retrocyclin-101 TFA |
Inhibitor |
/ |
Unkown |
| HY-RS12442 |
SAR1A Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-128788A |
ddhCTP trisodium solution (100 mM) |
Inhibitor |
/ |
Unkown |
| HY-131603B |
Lamivudine triphosphate TEA |
Inhibitor |
/ |
Unkown |
| HY-132191 |
Pradimicin A |
Inhibitor |
/ |
Unkown |
| HY-14830 |
SAR 97276 |
Inhibitor |
98.05% |
Unkown |
| HY-169171 |
Cathepsin L-IN-5 |
Inhibitor |
/ |
Unkown |
| HY-B0190S1 |
Nafamostat formate salt-13C6 |
|
98.11% |
Unkown |
| HY-N0063R |
Punicalagin (Standard) |
Inhibitor |
98.39% |
Unkown |
| HY-N8693 |
Withanoside IV |
|
98.47% |
Unkown |
| HY-162177 |
SARS-CoV-2-IN-78 |
Inhibitor |
/ |
Unkown |
| HY-145115 |
Adeninobananin |
Control |
/ |
Unkown |
| HY-135860 |
SARS-CoV-2-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-151113 |
ZINC000104379474 |
Inhibitor |
/ |
Unkown |
| HY-18234 |
Leupeptin |
Inhibitor |
/ |
Unkown |
| HY-100546 |
GSK-LSD1 |
Inhibitor |
/ |
Unkown |
| HY-136606 |
SARS-CoV MPro-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-150681 |
SARS-CoV-2 nsp14-IN-2 |
Inhibitor |
/ |
Unkown |
| HY-183746 |
Catechin-5-O-gallate |
Inhibitor |
/ |
Unkown |
| HY-183885 |
MPI3 |
Inhibitor |
/ |
Unkown |
| HY-90001S |
Ritonavir-d6 |
|
98.84% |
Unkown |
| HY-P3492 |
SARS-CoV-2-IN-34 |
Inhibitor |
/ |
Unkown |
| HY-10237S |
Boceprevir-d9 |
Inhibitor |
/ |
Unkown |
| HY-14393S |
Emodin-d4 |
Inhibitor |
/ |
Unkown |
| HY-17367S2 |
Atazanavir-d9 |
|
/ |
Unkown |
| HY-17367S3 |
Atazanavir-d5 |
|
/ |
Unkown |
| HY-17430S |
Amprenavir-d4 |
Inhibitor |
/ |
Unkown |
| HY-100211A |
(R)-TAPI-2 |
Control |
/ |
Unkown |
| HY-100701 |
Dutacatib |
Inhibitor |
/ |
Unkown |
| HY-10235S |
Telaprevir-d4 |
Inhibitor |
/ |
Unkown |
| HY-10241S |
Simeprevir-13C,d3 |
Inhibitor |
/ |
Unkown |
| HY-104077S2 |
Remdesivir impurity 9-d4 |
Inhibitor |
/ |
Unkown |
| HY-105026 |
Cistinexine |
|
/ |
Unkown |
| HY-105690 |
SAR-115740 |
Antagonist |
/ |
Unkown |
| HY-105721 |
Aranotin |
Inhibitor |
/ |
Unkown |
| HY-106560 |
Proglumetacin |
Inhibitor |
/ |
Unkown |
| HY-10661 |
FL104 |
Agonist |
/ |
Unkown |
| HY-106979 |
Olcorolimus |
Inhibitor |
/ |
Unkown |
| HY-108137A |
Z-L(D-Val)G-CHN2 |
Inhibitor |
99.35% |
Unkown |
| HY-108511A |
PB28 |
|
/ |
Unkown |
| HY-110265 |
SAR216471 hydrochloride |
Antagonist |
/ |
Unkown |
| HY-111970 |
SAR113945 |
Inhibitor |
/ |
Unkown |
| HY-112894 |
ZG-10 |
Inhibitor |
/ |
Unkown |
| HY-118326 |
MRT 68601 |
|
/ |
Unkown |
| HY-119293A |
K777 tosylate |
Inhibitor |
/ |
Unkown |
| HY-120167 |
YM-44778 |
Antagonist |
/ |
Unkown |
| HY-121068 |
Bisoxatin |
Inhibitor |
/ |
Unkown |
| HY-121421 |
Diniprofylline |
Inhibitor |
/ |
Unkown |
| HY-123050 |
(Rac)-SAR131675 |
Inhibitor |
/ |
Unkown |
| HY-12435 |
SAR216471 |
Antagonist |
/ |
Unkown |
| HY-124439 |
Setomimycin |
Inhibitor |
/ |
Unkown |
| HY-12476 |
SAR156497 |
Inhibitor |
/ |
Unkown |
| HY-12530S3 |
Velpatasvir-13C,d3 |
|
/ |
Unkown |
| HY-12605 |
SAR107375 |
Inhibitor |
/ |
Unkown |
| HY-126416 |
Methyl tanshinonate |
Inhibitor |
/ |
Unkown |
| HY-126937S |
Ivermectin B1a-d2-1 |
Inhibitor |
/ |
Unkown |
| HY-127083 |
Artecanin |
Inhibitor |
/ |
Unkown |
| HY-128427 |
PLpro-IN-1 |
Inhibitor |
99.28% |
Unkown |
| HY-128788 |
ddhCTP |
Inhibitor |
/ |
Unkown |
| HY-131262 |
Hydroxychloroquine Impurity E |
|
99.83% |
Unkown |
| HY-131263 |
Hydroxychloroquine Impurity F |
|
/ |
Unkown |
| HY-131275 |
Imatinib Impurity E |
|
96.05% |
Unkown |
| HY-131603 |
Lamivudine triphosphate |
Inhibitor |
/ |
Unkown |
| HY-132280R |
Tirilazad (Standard) |
Inhibitor |
/ |
Unkown |
| HY-133135 |
CHIKV-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-133832 |
Elopiprazole |
Inhibitor |
/ |
Unkown |
| HY-134222AS |
N-Acetylserine-d3 |
|
/ |
Unkown |
| HY-139165 |
AT-9010 |
Inhibitor |
/ |
Unkown |
| HY-139732 |
SARS-CoV-2-IN-8 |
Inhibitor |
/ |
Unkown |
| HY-139866 |
SARS-CoV-2-IN-9 |
Inhibitor |
/ |
Unkown |
| HY-139892 |
XR8-69 |
Inhibitor |
/ |
Unkown |
| HY-143417 |
SARS-CoV-2-IN-16 |
Inhibitor |
/ |
Unkown |
| HY-143418 |
SARS-CoV-2-IN-17 |
Inhibitor |
/ |
Unkown |
| HY-143467 |
SARS-CoV-IN-4 |
Inhibitor |
/ |
Unkown |
| HY-143470 |
SARS-CoV-2-IN-18 |
Inhibitor |
/ |
Unkown |
| HY-144061 |
INSCoV-601I(1) |
|
/ |
Unkown |
| HY-144062 |
INSCoV-614(1B) |
|
/ |
Unkown |
| HY-144063 |
INSCoV-600K(1) |
|
/ |
Unkown |
| HY-144120 |
αGalCer-RBD |
Inhibitor |
/ |
Unkown |
| HY-144260 |
3CPLro-IN-1 |
|
/ |
Unkown |
| HY-144263 |
3CPLro-IN-2 |
|
/ |
Unkown |
| HY-144464 |
SARS-CoV-2 Mpro-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-144623 |
Antiviral agent 15 |
Inhibitor |
/ |
Unkown |
| HY-144647 |
SP inhibitor 1 |
Inhibitor |
/ |
Unkown |
| HY-144648 |
Mpro/PLpro-IN-1 |
|
/ |
Unkown |
| HY-144747 |
Hydroxyethylamine |
Inhibitor |
/ |
Unkown |
| HY-144798 |
FWM-5 |
Inhibitor |
/ |
Unkown |
| HY-144799 |
FWM-4 |
Inhibitor |
/ |
Unkown |
| HY-144833 |
SARS-CoV-2 3CLpro-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-145276 |
SARS-CoV-2-IN-10 |
Inhibitor |
/ |
Unkown |
| HY-145277 |
SARS-CoV-2-IN-11 |
Inhibitor |
/ |
Unkown |
| HY-145435 |
SARS-CoV-2-IN-12 |
Inhibitor |
/ |
Unkown |
| HY-14588S |
(rel)-Lopinavir-d8 |
Inhibitor |
/ |
Unkown |
| HY-14588S2 |
Lopinavir-d7 |
Inhibitor |
/ |
Unkown |
| HY-145949 |
Remdesivir de(ethylbutyl 2-aminopropanoate) |
|
/ |
Unkown |
| HY-145973B |
3'OMe-m7GpppAmpG Tris |
Inhibitor |
/ |
Unkown |
| HY-146157 |
SARS-CoV-2-IN-22 |
Inhibitor |
/ |
Unkown |
| HY-146248 |
TFMU-ADPr |
|
/ |
Unkown |
| HY-146379 |
SARS-CoV-2-IN-19 |
Inhibitor |
/ |
Unkown |
| HY-146381 |
SARS-CoV-2-IN-20 |
Inhibitor |
/ |
Unkown |
| HY-146987 |
FWM-3 |
Inhibitor |
/ |
Unkown |
| HY-147336 |
Desmethylazelastine |
|
/ |
Unkown |
| HY-147516 |
SARS-CoV-2-IN-21 |
Inhibitor |
/ |
Unkown |
| HY-147804 |
SARS-CoV-2 3CLpro-IN-3 |
Inhibitor |
/ |
Unkown |
| HY-147805 |
SARS-CoV-2 3CLpro-IN-4 |
Inhibitor |
/ |
Unkown |
| HY-147844 |
F8-S43-S3 |
Inhibitor |
/ |
Unkown |
| HY-147845 |
F8-S40 |
Inhibitor |
/ |
Unkown |
| HY-148387 |
SARS-CoV-2-IN-35 |
Inhibitor |
/ |
Unkown |
| HY-148705 |
Isomitomycin A |
Inhibitor |
/ |
Unkown |
| HY-149050 |
Viral polymerase-IN-1 hydrochloride |
Inhibitor |
/ |
Unkown |
| HY-149256 |
PLpro/RBD-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-149263 |
HAA-09 |
Inhibitor |
/ |
Unkown |
| HY-149267 |
STING agonist-30 |
|
/ |
Unkown |
| HY-149304 |
SARS-CoV-2-IN-40 |
Inhibitor |
/ |
Unkown |
| HY-149314 |
SARS-CoV-2-IN-47 |
Inhibitor |
/ |
Unkown |
| HY-149315 |
SARS-CoV-2-IN-48 |
Inhibitor |
/ |
Unkown |
| HY-149317 |
ZINC475239213 |
Inhibitor |
/ |
Unkown |
| HY-149319 |
ZINC61142882 |
Inhibitor |
/ |
Unkown |
| HY-149320 |
Acryl42-10 |
Inhibitor |
/ |
Unkown |
| HY-149322 |
Z795161988 |
Inhibitor |
/ |
Unkown |
| HY-149368 |
SARS-CoV-2-IN-51 |
Inhibitor |
/ |
Unkown |
| HY-149655 |
D1N8 |
Inhibitor |
/ |
Unkown |
| HY-149656 |
D1N52 |
Inhibitor |
/ |
Unkown |
| HY-149767 |
CMX990 |
Inhibitor |
96.63% |
Unkown |
| HY-149774 |
GC-78-HCl |
|
/ |
Unkown |
| HY-149868 |
SARS-CoV-2-IN-42 |
Inhibitor |
/ |
Unkown |
| HY-149940 |
SIMR3030 |
Inhibitor |
/ |
Unkown |
| HY-149955 |
SARS-CoV-2-IN-38 |
Inhibitor |
/ |
Unkown |
| HY-150064 |
SARS-CoV-2 nsp3-IN-2 |
|
/ |
Unkown |
| HY-150258 |
TRK-IN-22 |
Inhibitor |
/ |
Unkown |
| HY-150322 |
SAR-7226 |
Inhibitor |
/ |
Unkown |
| HY-150558 |
CYP1B1-IN-2 |
Inhibitor |
/ |
Unkown |
| HY-150623 |
SARS-CoV-2 nsp13-IN-2 |
Inhibitor |
/ |
Unkown |
| HY-150624 |
SARS-CoV-2 nsp13-IN-3 |
Inhibitor |
/ |
Unkown |
| HY-150625 |
SARS-CoV-2 nsp13-IN-4 |
Inhibitor |
/ |
Unkown |
| HY-150626 |
SARS-CoV-2 nsp13-IN-5 |
Inhibitor |
/ |
Unkown |
| HY-150632 |
SARS-CoV-2 nsp13-IN-6 |
Inhibitor |
/ |
Unkown |
| HY-150680 |
SARS-CoV-2 nsp14-IN-1 |
|
/ |
Unkown |
| HY-150691 |
SARS 3CLpro-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-150783 |
SARS-CoV-2-IN-24 |
Inhibitor |
/ |
Unkown |
| HY-150786 |
PLP_Snyder530 |
Inhibitor |
/ |
Unkown |
| HY-150789 |
SARS-CoV-2-IN-23 |
Inhibitor |
/ |
Unkown |
| HY-151265 |
MMT5-14 |
Inhibitor |
/ |
Unkown |
| HY-151267 |
SARS-CoV-2-IN-25 |
Inhibitor |
/ |
Unkown |
| HY-151267A |
SARS-CoV-2-IN-25 disodium |
Inhibitor |
/ |
Unkown |
| HY-151269 |
SARS-CoV-2-IN-26 |
Inhibitor |
/ |
Unkown |
| HY-151269A |
SARS-CoV-2-IN-23 disodium |
Inhibitor |
/ |
Unkown |
| HY-151271 |
SARS-CoV-2-IN-27 |
Inhibitor |
/ |
Unkown |
| HY-151271A |
SARS-CoV-2-IN-27 disodium |
Inhibitor |
/ |
Unkown |
| HY-151274 |
SARS-CoV-2-IN-28 |
Inhibitor |
/ |
Unkown |
| HY-151274A |
SARS-CoV-2-IN-28 disodium |
Inhibitor |
/ |
Unkown |
| HY-151276 |
SARS-CoV-2-IN-29 |
Inhibitor |
/ |
Unkown |
| HY-151276A |
SARS-CoV-2-IN-29 disodium |
Inhibitor |
/ |
Unkown |
| HY-151278 |
SARS-CoV-2-IN-30 |
Inhibitor |
/ |
Unkown |
| HY-151278A |
SARS-CoV-2-IN-30 disodium |
Inhibitor |
/ |
Unkown |
| HY-151474 |
SARS-CoV-2-IN-31 |
Inhibitor |
99.09% |
Unkown |
| HY-151477 |
SARS-CoV-2-IN-32 |
Inhibitor |
99.58% |
Unkown |
| HY-151478 |
SARS-CoV-2-IN-33 |
Inhibitor |
99.02% |
Unkown |
| HY-15148S1 |
Tipranavir-d7 |
Inhibitor |
98.94% |
Unkown |
| HY-151497 |
Antimicrobial agent-10 |
Inhibitor |
/ |
Unkown |
| HY-151501 |
Antimicrobial agent-11 |
Inhibitor |
/ |
Unkown |
| HY-151502 |
Antimicrobial agent-12 |
Inhibitor |
/ |
Unkown |
| HY-151535 |
SARS-CoV-2 3CLpro-IN-5 |
Inhibitor |
/ |
Unkown |
| HY-151608 |
SARS-CoV-2 Mpro-IN-3 |
Inhibitor |
/ |
Unkown |
| HY-151900 |
SARS-CoV-2 Mpro-IN-4 |
Inhibitor |
/ |
Unkown |
| HY-151901 |
SARS-CoV-2 Mpro-IN-5 |
Inhibitor |
/ |
Unkown |
| HY-151988 |
SARS-CoV-2-IN-36 |
Inhibitor |
/ |
Unkown |
| HY-151990 |
SARS-CoV-2/MERS Mpro-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-151991 |
SARS-CoV-2/MERS Mpro-IN-2 |
Inhibitor |
/ |
Unkown |
| HY-152005 |
SARS-CoV-2 3CLpro-IN-6 |
Inhibitor |
/ |
Unkown |
| HY-152009 |
SARS-CoV-2 3CLpro-IN-7 |
Inhibitor |
/ |
Unkown |
| HY-152108 |
SARS-CoV-2 Mpro-IN-6 |
Inhibitor |
/ |
Unkown |
| HY-152220 |
SPR39 |
Inhibitor |
/ |
Unkown |
| HY-152222 |
SPR38 |
Inhibitor |
/ |
Unkown |
| HY-152224 |
SPR41 |
Inhibitor |
/ |
Unkown |
| HY-152589 |
Antiviral agent 25 |
Inhibitor |
/ |
Unkown |
| HY-152957 |
STING agonist-24 |
Agonist |
/ |
Unkown |
| HY-152958 |
STING agonist-25 |
Agonist |
/ |
Unkown |
| HY-152960 |
STING agonist-27 |
Agonist |
/ |
Unkown |
| HY-152961 |
STING agonist-28 |
Agonist |
/ |
Unkown |
| HY-152962 |
STING agonist-29 |
Agonist |
/ |
Unkown |
| HY-153719 |
NSC111552 |
Inhibitor |
/ |
Unkown |
| HY-154975 |
SARS-CoV-2-IN-49 |
Inhibitor |
/ |
Unkown |
| HY-154976 |
SARS-CoV-2-IN-50 |
Inhibitor |
/ |
Unkown |
| HY-154990 |
RdRP-IN-7 |
Inhibitor |
/ |
Unkown |
| HY-155013 |
SARS-CoV-2-IN-43 |
Inhibitor |
/ |
Unkown |
| HY-155014 |
SARS-CoV-2-IN-44 |
Inhibitor |
/ |
Unkown |
| HY-155015 |
SARS-CoV-2-IN-45 |
Inhibitor |
/ |
Unkown |
| HY-155016 |
SARS-CoV-2-IN-46 |
Inhibitor |
99.77% |
Unkown |
| HY-155056 |
SARS-CoV-2 Mpro-IN-7 |
Inhibitor |
/ |
Unkown |
| HY-155057 |
SARS-CoV-2 Mpro-IN-8 |
Inhibitor |
/ |
Unkown |
| HY-155097 |
SARS-CoV-2-IN-53 |
Inhibitor |
/ |
Unkown |
| HY-155119 |
SARS-CoV-2-IN-54 |
Inhibitor |
/ |
Unkown |
| HY-155121 |
SARS-CoV-2-IN-56 |
Inhibitor |
/ |
Unkown |
| HY-155136 |
NSC89641 |
Inhibitor |
/ |
Unkown |
| HY-155142 |
CDD-1819 |
Inhibitor |
/ |
Unkown |
| HY-155143 |
CDD-1733 |
Inhibitor |
/ |
Unkown |
| HY-155155 |
SARS-CoV-2-IN-57 |
Inhibitor |
/ |
Unkown |
| HY-155186 |
SARS-CoV-2 3CLpro-IN-19 |
Inhibitor |
/ |
Unkown |
| HY-155187 |
SARS-CoV-2 3CLpro-IN-20 |
Inhibitor |
97.09% |
Unkown |
| HY-155308 |
SARS-CoV-2-IN-61 |
Inhibitor |
/ |
Unkown |
| HY-155416 |
M56-S2 iodide |
Inhibitor |
/ |
Unkown |
| HY-155527 |
SARS-CoV-2 Mpro-IN-9 |
Inhibitor |
99.31% |
Unkown |
| HY-155540 |
SARS-CoV-2 3CLpro-IN-14 |
Inhibitor |
/ |
Unkown |
| HY-155654 |
SARS-CoV-2 Mpro-IN-10 |
Inhibitor |
/ |
Unkown |
| HY-155679 |
SARS-CoV-2 nsp14-IN-4 |
Inhibitor |
/ |
Unkown |
| HY-155734 |
SARS-CoV-2-IN-55 |
|
/ |
Unkown |
| HY-155979 |
SARS-CoV-2 3CLpro-IN-16 |
Inhibitor |
/ |
Unkown |
| HY-155980 |
SARS-CoV-2 3CLpro-IN-17 |
Inhibitor |
/ |
Unkown |
| HY-155981 |
SARS-CoV-2 3CLpro-IN-18 |
Inhibitor |
/ |
Unkown |
| HY-156008 |
SARS-CoV-2-IN-58 |
Inhibitor |
/ |
Unkown |
| HY-15602S |
Ledipasvir-d6 |
Inhibitor |
99.0% |
Unkown |
| HY-156325 |
SARS-CoV-2-IN-62 |
Inhibitor |
/ |
Unkown |
| HY-156337 |
SARS-CoV-2-IN-63 |
Inhibitor |
/ |
Unkown |
| HY-156441 |
SARS-CoV-2-IN-65 |
Inhibitor |
/ |
Unkown |
| HY-156459 |
SARS-CoV-2 Mpro-IN-12 |
Inhibitor |
/ |
Unkown |
| HY-156734 |
D-4-77 |
Inhibitor |
/ |
Unkown |
| HY-157021 |
SARS-CoV-2-IN-66 |
Inhibitor |
/ |
Unkown |
| HY-157477 |
SARS-CoV-2 3CLpro-IN-22 |
Inhibitor |
/ |
Unkown |
| HY-157804 |
PROTAC SARS-CoV-2 Mpro degrader-1 |
Inhibitor |
/ |
Unkown |
| HY-157805 |
PROTAC SARS-CoV-2 Mpro degrader-2 |
Degrader |
/ |
Unkown |
| HY-157928 |
Keap1-Nrf2-IN-18 |
Inhibitor |
/ |
Unkown |
| HY-157966 |
SARS-CoV-2 3CLpro-IN-23 |
Inhibitor |
/ |
Unkown |
| HY-157996 |
CSF1R-IN-21 |
Inhibitor |
/ |
Unkown |
| HY-158073 |
ML2006a4 |
Inhibitor |
/ |
Unkown |
| HY-158347 |
SARS-CoV-2 Mpro-IN-15 |
Inhibitor |
/ |
Unkown |
| HY-158422 |
SARS-CoV-2 Mpro-IN-16 |
Inhibitor |
/ |
Unkown |
| HY-158440 |
SARS-CoV-2 Mpro-IN-17 |
Inhibitor |
/ |
Unkown |
| HY-158569 |
SAR114137 |
|
/ |
Unkown |
| HY-15957 |
FASN-IN-7 |
Inhibitor |
/ |
Unkown |
| HY-159633 |
PLpro-IN-5 |
Inhibitor |
/ |
Unkown |
| HY-159655 |
PLpro-IN-6 |
Inhibitor |
/ |
Unkown |
| HY-159890 |
MTI013 |
Inhibitor |
/ |
Unkown |
| HY-161238 |
SARS-CoV-2-IN-79 |
Inhibitor |
/ |
Unkown |
| HY-161245 |
FGA146 |
Inhibitor |
/ |
Unkown |
| HY-161261 |
SARS-CoV-2-IN-81 |
Inhibitor |
/ |
Unkown |
| HY-161365 |
PLpro-IN-2 |
Inhibitor |
/ |
Unkown |
| HY-161371 |
VD5123 |
Inhibitor |
/ |
Unkown |
| HY-161722 |
SARS-CoV-2 Mpro-IN-21 |
Inhibitor |
/ |
Unkown |
| HY-161790 |
Mpro ligand 1 |
|
/ |
Unkown |
| HY-161791 |
Mpro ligand 2 |
|
/ |
Unkown |
| HY-161793 |
(S,R,S)-AHPC-NHCO-C-O-C5-N3 |
|
/ |
Unkown |
| HY-161844 |
Virapinib |
|
/ |
Unkown |
| HY-161919 |
SARS-CoV-2 3CLpro-IN-25 |
Inhibitor |
/ |
Unkown |
| HY-162151 |
SARS-CoV-2-IN-74 |
Inhibitor |
/ |
Unkown |
| HY-162154 |
SARS-CoV-2-IN-75 |
Inhibitor |
/ |
Unkown |
| HY-162229 |
GRL-190-21 |
Inhibitor |
/ |
Unkown |
| HY-162236 |
SARS-CoV-2-IN-80 |
Inhibitor |
/ |
Unkown |
| HY-162295 |
SARS-CoV-2-IN-83 |
Inhibitor |
/ |
Unkown |
| HY-162414 |
SARS-CoV-2-IN-84 |
Inhibitor |
/ |
Unkown |
| HY-162464 |
MPD2 |
Inhibitor |
/ |
Unkown |
| HY-162474 |
BZG2 |
Inhibitor |
/ |
Unkown |
| HY-162504 |
2'-RIBOTAC-U |
Inhibitor |
/ |
Unkown |
| HY-162507 |
2'-RIBOTAC-U recruiter-linker |
|
/ |
Unkown |
| HY-162701 |
Antiviral agent 58 |
Inhibitor |
/ |
Unkown |
| HY-162725 |
TLR7 agonist 24 |
Agonist |
/ |
Unkown |
| HY-162777 |
SARS-CoV-2-IN-93 |
Inhibitor |
/ |
Unkown |
| HY-162790 |
SARS-CoV-2-IN-95 |
Inhibitor |
/ |
Unkown |
| HY-162914 |
SARS-CoV-2-IN-96 |
Inhibitor |
/ |
Unkown |
| HY-162924 |
SARS-CoV-IN-6 |
Inhibitor |
/ |
Unkown |
| HY-162956 |
SARS-CoV-2-IN-97 |
Inhibitor |
/ |
Unkown |
| HY-163389 |
Mpro/Cathepsin L-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-163614 |
SARS-CoV-2-IN-87 |
Inhibitor |
/ |
Unkown |
| HY-163706 |
SARS-CoV-2-IN-88 |
Inhibitor |
/ |
Unkown |
| HY-163785 |
1"-α-Azido-RDPr |
Inhibitor |
/ |
Unkown |
| HY-163857 |
SARS-CoV-2-IN-91 |
Inhibitor |
/ |
Unkown |
| HY-163912 |
JZD-07 |
Inhibitor |
/ |
Unkown |
| HY-167960 |
BrAc-Galactose-Sar-N-Me-alanine-DM1 |
|
/ |
Unkown |
| HY-168107 |
SARS-CoV-2-IN-98 |
Inhibitor |
/ |
Unkown |
| HY-168152 |
SARS-CoV-2 3CLpro-IN-26 |
Inhibitor |
/ |
Unkown |
| HY-168259 |
PLpro-IN-8 |
Inhibitor |
/ |
Unkown |
| HY-168430 |
SARS-CoV-2 3CLpro-IN-30 |
Inhibitor |
/ |
Unkown |
| HY-168441 |
NCGC00537446 |
Inhibitor |
/ |
Unkown |
| HY-168455 |
RNAse L RIBOTAC |
|
/ |
Unkown |
| HY-168557 |
SARS-CoV-2-IN-101 |
Inhibitor |
/ |
Unkown |
| HY-168564 |
SARS-CoV-2 3CLpro-IN-27 |
Inhibitor |
/ |
Unkown |
| HY-168568 |
SARS-CoV-2 Mpro-IN-28 |
Inhibitor |
/ |
Unkown |
| HY-168599 |
SARS-CoV-2 Mpro-IN-31 |
Inhibitor |
/ |
Unkown |
| HY-168600 |
SARS-CoV-2 Mpro-IN-32 |
Inhibitor |
/ |
Unkown |
| HY-168916 |
Jun13296 |
Inhibitor |
/ |
Unkown |
| HY-169055 |
SARS-CoV-2 Mpro-IN-25 |
Inhibitor |
/ |
Unkown |
| HY-169224 |
SARS-CoV-2-IN-100 |
Inhibitor |
/ |
Unkown |
| HY-169256 |
ZINC4497834 |
Inhibitor |
/ |
Unkown |
| HY-169260 |
SARS-CoV-2 Mpro-IN-27 |
Inhibitor |
/ |
Unkown |
| HY-169340 |
SAR-150640 |
Agonist |
/ |
Unkown |
| HY-169405 |
AAK1/HDACs-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-169410 |
SARS-CoV-2 3CLpro-IN-29 |
Inhibitor |
/ |
Unkown |
| HY-169419 |
SARS-CoV-2-IN-108 |
Inhibitor |
/ |
Unkown |
| HY-169847 |
ZK-806450 |
|
/ |
Unkown |
| HY-169977 |
CKP-25 |
Inhibitor |
/ |
Unkown |
| HY-169997 |
LU9 |
Inhibitor |
/ |
Unkown |
| HY-170309 |
NZ-804 |
Inhibitor |
/ |
Unkown |
| HY-170357 |
SARS-CoV-2 3CLpro-IN-28 |
Inhibitor |
/ |
Unkown |
| HY-17042AS1 |
Cetirizine-d8 dihydrochloride |
Antagonist |
99.64% |
Unkown |
| HY-170515A |
(E),(Z)-RNF5 agonist 1 |
|
/ |
Unkown |
| HY-170523 |
RU-0415529 |
Inhibitor |
/ |
Unkown |
| HY-170598 |
HP211206 |
Inhibitor |
/ |
Unkown |
| HY-170767 |
SARS-CoV-2-IN-109 |
Inhibitor |
/ |
Unkown |
| HY-170799 |
HNC-1664 |
Inhibitor |
/ |
Unkown |
| HY-171781 |
FL-166 |
Inhibitor |
/ |
Unkown |
| HY-172214 |
AB-343 |
Inhibitor |
/ |
Unkown |
| HY-172265 |
FKBP12 PROTAC FM4 |
Degrader |
99.95% |
Unkown |
| HY-172350 |
WEHI-P8 |
Inhibitor |
/ |
Unkown |
| HY-172960 |
SARS-CoV-2 Mpro-IN-44 |
Inhibitor |
/ |
Unkown |
| HY-172965 |
SARS-CoV-2 Mpro-IN-43 |
|
/ |
Unkown |
| HY-173411 |
DNJ-20 |
Inhibitor |
/ |
Unkown |
| HY-17367S4 |
Atazanavir-d6 |
|
99.28% |
Unkown |
| HY-174224 |
Amb929 |
Inhibitor |
/ |
Unkown |
| HY-174233 |
PROTAC SARS-CoV-2 Mpro degrader-4 |
Degrader |
/ |
Unkown |
| HY-174235 |
Thalidomide-OCH2-amide-PEG2-C2-Boc |
|
/ |
Unkown |
| HY-17430S1 |
Amprenavir-d4-1 |
Inhibitor |
/ |
Unkown |
| HY-174350 |
CK2-IN-15 |
Inhibitor |
/ |
Unkown |
| HY-174370 |
MePT-S-N-Pme |
Inhibitor |
/ |
Unkown |
| HY-174373 |
SARS-CoV-2-IN-113 |
Inhibitor |
/ |
Unkown |
| HY-175344 |
TMP1 |
Inhibitor |
/ |
Unkown |
| HY-175461 |
AVI-4206 |
Inhibitor |
/ |
Unkown |
| HY-17589S |
Chloroquine-d5 diphosphate |
Inhibitor |
/ |
Unkown |
| HY-176211 |
SARS-CoV-2 Mpro-IN-45 |
Inhibitor |
/ |
Unkown |
| HY-176264 |
DNDI-6510 |
Inhibitor |
/ |
Unkown |
| HY-177303 |
AXT-914 |
Inhibitor |
98.83% |
Unkown |
| HY-177663 |
SARSi-4 sodium |
Inhibitor |
/ |
Unkown |
| HY-177884 |
Triptolide-6-β-D-glucose |
|
/ |
Unkown |
| HY-177885 |
Triptolide-6-methoxy-β-D-glucose |
|
/ |
Unkown |
| HY-178025 |
TDI-014925 |
Inhibitor |
/ |
Unkown |
| HY-178135 |
SCR005 |
Inhibitor |
/ |
Unkown |
| HY-178137 |
SCR007 |
Inhibitor |
/ |
Unkown |
| HY-178156 |
DHODH-IN-31 |
Inhibitor |
99.55% |
Unkown |
| HY-178160 |
SARS-CoV-2 PLpro-IN-2 |
Inhibitor |
/ |
Unkown |
| HY-178374 |
BACE-1/Mpro-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-178772 |
SARS-CoV-2 Mpro-IN-50 |
Inhibitor |
/ |
Unkown |
| HY-179088 |
AVI-6451 |
Inhibitor |
/ |
Unkown |
| HY-179249 |
Fluoroneplanocin A-8N |
Inhibitor |
/ |
Unkown |
| HY-179269 |
SARS-CoV-2 nsp14-IN-9 |
Inhibitor |
/ |
Unkown |
| HY-179283 |
PROTAC SARS-CoV-2 RdRp Degrader-1 |
|
/ |
Unkown |
| HY-179293 |
SARS-CoV-2 PLpro-IN-3 |
Inhibitor |
/ |
Unkown |
| HY-179334 |
DMA-155 |
Inhibitor |
/ |
Unkown |
| HY-179556 |
SARS-CoV-2 nsp14-IN-10 |
|
/ |
Unkown |
| HY-179567 |
NVP-EGT710 |
Inhibitor |
/ |
Unkown |
| HY-179617 |
Cbl-b-IN-30 |
Inhibitor |
/ |
Unkown |
| HY-179634 |
ASF-006 sodium |
Inhibitor |
/ |
Unkown |
| HY-179703 |
FXR agonist 15 |
Agonist |
/ |
Unkown |
| HY-180194 |
SERCA2a activator 2 |
Activator |
/ |
Unkown |
| HY-180318 |
MI-30 |
Inhibitor |
/ |
Unkown |
| HY-180332 |
NSC-624871 |
Inhibitor |
/ |
Unkown |
| HY-180405 |
UAWJ-247 |
Inhibitor |
/ |
Unkown |
| HY-180578 |
MWAC-3429 |
Inhibitor |
/ |
Unkown |
| HY-180792 |
CK-571 |
Inhibitor |
/ |
Unkown |
| HY-180816 |
PRMT5-MTA-IN-7 |
Inhibitor |
/ |
Unkown |
| HY-181033 |
(M)-AVI-4773 |
Inhibitor |
/ |
Unkown |
| HY-181066 |
ACE2-SP PPI-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-181263 |
Jun13698 |
Inhibitor |
/ |
Unkown |
| HY-181352 |
SB-140 |
Inhibitor |
/ |
Unkown |
| HY-181489 |
SARS-CoV-2 3CLpro-IN-35 |
Inhibitor |
/ |
Unkown |
| HY-181606 |
Cyclo(phg-isoDGR-k)-PEG4-non-cleavable-SAR405838 |
|
/ |
Unkown |
| HY-181661 |
YL1004 |
Inhibitor |
/ |
Unkown |
| HY-181778 |
RdRP-IN-10 |
Inhibitor |
/ |
Unkown |
| HY-181904 |
SARS-CoV-2 Mpro ligand 2 |
Ligand |
/ |
Unkown |
| HY-181905 |
(S,R,S)-AHPC-Me-C2-piperazine |
|
/ |
Unkown |
| HY-181983 |
VPC285785 |
Inhibitor |
/ |
Unkown |
| HY-182024 |
SARS-CoV-2 3CLpro-IN-36 |
Inhibitor |
/ |
Unkown |
| HY-182065 |
SARS-CoV-2 Mpro-IN-56 |
Inhibitor |
/ |
Unkown |
| HY-182252 |
SAR296968 |
Inhibitor |
/ |
Unkown |
| HY-182894 |
MR1-114 |
Inhibitor |
/ |
Unkown |
| HY-182913 |
SARS-CoV-2-IN-122 |
Inhibitor |
/ |
Unkown |
| HY-183185 |
BZ-30 |
Inhibitor |
/ |
Unkown |
| HY-183266 |
SR-A-174 |
Inhibitor |
/ |
Unkown |
| HY-183752 |
CG-0988 |
Inhibitor |
/ |
Unkown |
| HY-183761 |
Antiviral agent 86 |
Inhibitor |
/ |
Unkown |
| HY-183940 |
Cathepsin L-IN-7 |
Inhibitor |
/ |
Unkown |
| HY-18986S |
SAR405838-d10 |
|
/ |
Unkown |
| HY-19195 |
TO-195 (hydrochlorid) |
Inhibitor |
/ |
Unkown |
| HY-203876 |
Sar10 |
|
/ |
Unkown |
| HY-44484 |
MAC-5576 |
|
/ |
Unkown |
| HY-90001S1 |
Ritonavir-13C,d3 |
|
/ |
Unkown |
| HY-90001S2 |
Ritonavir-d8 |
|
/ |
Unkown |
| HY-B0462AS |
Azelastine-13C,d3 |
|
/ |
Unkown |
| HY-B0462B |
(S)-Azelastine hydrochloride |
|
/ |
Unkown |
| HY-B0462S |
Azelastine-13C,d3 hydrochloride |
|
/ |
Unkown |
| HY-B1370S |
Hydroxychloroquine-d4 sulfate |
Inhibitor |
/ |
Unkown |
| HY-B1624C |
Debrisoquin hydrobromide |
Inhibitor |
/ |
Unkown |
| HY-B2074 |
Demexiptiline |
Ligand |
/ |
Unkown |
| HY-D2342 |
SARS-CoV-2 3CLpro probe-1 |
|
/ |
Unkown |
| HY-E70610 |
SARS-CoV-2 main protease |
|
/ |
Unkown |
| HY-G0017A |
N-Desmethyl imatinib mesylate |
|
/ |
Unkown |
| HY-G0017R |
N-Desmethyl imatinib (Standard) |
|
/ |
Unkown |
| HY-G0017S1 |
N-Desmethyl imatinib-d4 |
|
/ |
Unkown |
| HY-N10118 |
NK007 |
Inhibitor |
/ |
Unkown |
| HY-N10604 |
Dihydromaniwamycin E |
Inhibitor |
/ |
Unkown |
| HY-N10605 |
Maniwamycin E |
Inhibitor |
/ |
Unkown |
| HY-N10661 |
Ipomoeassin F |
Inhibitor |
/ |
Unkown |
| HY-N11896A |
10-Hydroxyaloin A |
Inhibitor |
/ |
Unkown |
| HY-N14351 |
Ferrocin A |
Inhibitor |
/ |
Unkown |
| HY-N144101 |
SARS-CoV MPro-IN-2 |
Inhibitor |
/ |
Unkown |
| HY-N15365 |
Antcin B |
Inhibitor |
/ |
Unkown |
| HY-N16586 |
Apigenin 7,4'-di-O-alloside |
Inhibitor |
/ |
Unkown |
| HY-N1836 |
3-Acetonyl-3-hydroxyoxindole |
Inhibitor |
/ |
Unkown |
| HY-N7378A |
N-Hydroxypipecolic acid potassium |
|
/ |
Unkown |
| HY-N9664 |
Crepidiaside B |
Inhibitor |
/ |
Unkown |
| HY-P10344 |
MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2 |
|
/ |
Unkown |
| HY-P10466 |
KZR-8445 |
Inhibitor |
/ |
Unkown |
| HY-P10466A |
KZR-8445 TFA |
Inhibitor |
/ |
Unkown |
| HY-P10555 |
(D-Arg2, Sar 4)-Dermorphin (1-4) |
Agonist |
/ |
Unkown |
| HY-P10640 |
[Sar1,Thr8]-Angiotensin II |
Antagonist |
/ |
Unkown |
| HY-P10688 |
NQK-Q8 peptide |
|
/ |
Unkown |
| HY-P10803 |
FLDKFNHEAEDLFYQSSL |
Inhibitor |
/ |
Unkown |
| HY-P10855 |
S1b3inL1 |
Inhibitor |
/ |
Unkown |
| HY-P10858 |
UCI-1 |
Inhibitor |
/ |
Unkown |
| HY-P10872 |
P315V3 |
Inhibitor |
/ |
Unkown |
| HY-P10975 |
P9R |
Inhibitor |
/ |
Unkown |
| HY-P10976 |
Spike Glycoprotein (1147-1162) |
Inhibitor |
/ |
Unkown |
| HY-P11012 |
EK1 |
Inhibitor |
/ |
Unkown |
| HY-P11389 |
(Sar1,Gly8)-Angiotensin II |
Antagonist |
/ |
Unkown |
| HY-P11464 |
SARS-CoV-2 Spike receptor binding domain, RBD (371-394) |
|
/ |
Unkown |
| HY-P11470 |
Conofurin-Delta |
Inhibitor |
/ |
Unkown |
| HY-P11579 |
TLP-3 |
Inhibitor |
/ |
Unkown |
| HY-P2296 |
Abz-FRLKGGAPIKGV-EDDNP TFA |
|
/ |
Unkown |
| HY-P3258 |
SP-10 |
|
/ |
Unkown |
| HY-P3905 |
[Glp5,Sar9] Substance P (5-11) |
|
/ |
Unkown |
| HY-P3927 |
[MePhe8,Sar9] Substance P |
|
/ |
Unkown |
| HY-P3932 |
[Sar4] Substance P (4-11) |
|
/ |
Unkown |
| HY-P4296 |
H-Gly-Sar-Sar-OH |
|
/ |
Unkown |
| HY-P4307 |
Antioxidant agent-9 |
Inhibitor |
/ |
Unkown |
| HY-P4475 |
Sar-Pro-Arg-pNA |
|
/ |
Unkown |
| HY-P5168AS |
GPSVFPLAPSSK-13C6,15N2 TFA |
Inhibitor |
/ |
Unkown |
| HY-P5398 |
HR2-18 |
Inhibitor |
/ |
Unkown |
| HY-P5522 |
TriDAP |
|
/ |
Unkown |
| HY-P5642 |
Retrocyclin-101 |
Inhibitor |
/ |
Unkown |
| HY-P5827 |
SBP1 peptide |
|
/ |
Unkown |
| HY-P5975 |
Z-Leu-Leu-Leu-fluoromethyl ketone |
Inhibitor |
/ |
Unkown |
| HY-RS12443 |
SAR1B Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS12448 |
SARS1 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS12449 |
SARS2 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-W031727S1 |
Hydroxychloroquine-d5 |
|
/ |
Unkown |
| HY-W096127 |
Biotin-sar-oh |
|
/ |
Unkown |
| HY-W348072 |
SARS-CoV-2-IN-59 |
Inhibitor |
/ |
Unkown |
| HY-W423489 |
SARS-CoV-2-IN-76 |
Inhibitor |
/ |
Unkown |
| HY-W699983 |
Imidazole-15N2 |
Inhibitor |
98.56% |
Unkown |
| HY-W707562 |
FOY 251-d4 |
|
/ |
Unkown |
| HY-W744206 |
Azelastine-d3 |
|
/ |
Unkown |
| HY-W760546 |
SARS-CoV-2 3CLpro-IN-15 |
Inhibitor |
/ |
Unkown |
| HY-W777545 |
4-[(7-Chloro-4-quinolinyl)amino]-1-pentanol-d4 |
|
/ |
Unkown |
| HY-W816575 |
MDI-403 |
|
/ |
Unkown |
| HY-Y0189S |
Methyl Salicylate-d4 |
|
99.8% |
Unkown |
| HY-100442S |
Paquinimod-d5 |
Inhibitor |
/ |
Unkown |
| HY-100661 |
Cetirizine Impurity D |
Antagonist |
/ |
Unkown |
| HY-101823A |
A-81282 |
Antagonist |
/ |
Unkown |
| HY-108325S |
Brequinar-d3 |
Inhibitor |
/ |
Unkown |
| HY-109037S |
Mavacamten-d6 |
Modulator |
/ |
Unkown |
| HY-109037S2 |
Mavacamten-d1 |
Modulator |
/ |
Unkown |
| HY-111074 |
DB12055 |
Inhibitor |
/ |
Unkown |
| HY-112905 |
AN11736 |
Inhibitor |
/ |
Unkown |
| HY-116143 |
MAGL-IN-12 |
Inhibitor |
/ |
Unkown |
| HY-119980BS |
Fluphenazine-d6 hydrochloride |
|
/ |
Unkown |
| HY-121020 |
Arcapillin |
Inhibitor |
/ |
Unkown |
| HY-123185 |
(Rac)-Z-FA-FMK |
Inhibitor |
/ |
Unkown |
| HY-12530S1 |
Velpatasvir-d3 |
Inhibitor |
/ |
Unkown |
| HY-12605S |
SAR107375-d11 Tartrate |
Inhibitor |
/ |
Unkown |
| HY-133828 |
Cinanserin |
|
/ |
Unkown |
| HY-136967 |
Mergocriptine |
|
/ |
Unkown |
| HY-138687S1 |
Nirmatrelvir-d6 |
Inhibitor |
/ |
Unkown |
| HY-139111 |
Oxocarbazate |
Inhibitor |
/ |
Unkown |
| HY-139355 |
(S)-GS-621763 |
Control |
/ |
Unkown |
| HY-14588S1 |
Lopinavir-d8 |
Inhibitor |
/ |
Unkown |
| HY-14904AS |
Umifenovir-d6 hydrochloride |
Inhibitor |
98.0% |
Unkown |
| HY-14909R |
Bardoxolone (Standard) |
|
/ |
Unkown |
| HY-149649 |
SARS-CoV-2-IN-64 |
Inhibitor |
/ |
Unkown |
| HY-149799 |
28-O-Imidazolyl-azepano-betulin |
Inhibitor |
/ |
Unkown |
| HY-15463S3 |
Imatinib-13C,d3 |
|
/ |
Unkown |
| HY-155601 |
SARS-CoV-2-IN-52 |
Inhibitor |
/ |
Unkown |
| HY-156007 |
SARS-CoV-2 3CLpro-IN-21 |
Inhibitor |
/ |
Unkown |
| HY-15602S1 |
Ledipasvir-d16 |
Inhibitor |
/ |
Unkown |
| HY-157022 |
SARS-CoV-2-IN-67 |
Inhibitor |
/ |
Unkown |
| HY-157144 |
SARS-CoV-2-IN-68 |
Inhibitor |
/ |
Unkown |
| HY-157145 |
SARS-CoV-2-IN-69 |
Inhibitor |
/ |
Unkown |
| HY-157305 |
Jun11165 |
Inhibitor |
/ |
Unkown |
| HY-157439 |
SARS-CoV-2-IN-72 |
Inhibitor |
/ |
Unkown |
| HY-157539 |
PB49673382 |
Inhibitor |
/ |
Unkown |
| HY-157848 |
SARS-CoV-2-IN-82 |
Inhibitor |
/ |
Unkown |
| HY-158687 |
SARS-CoV-2 Mpro-IN-18 |
Inhibitor |
/ |
Unkown |
| HY-158751 |
Jun9-72-2 |
Inhibitor |
/ |
Unkown |
| HY-158763 |
MPI8 |
Inhibitor |
/ |
Unkown |
| HY-158905 |
MTDB-Alkyne |
Degrader |
/ |
Unkown |
| HY-159477 |
SARS-CoV-2-IN-92 |
Inhibitor |
/ |
Unkown |
| HY-159911 |
SARS-CoV-2 Mpro-IN-29 |
Inhibitor |
/ |
Unkown |
| HY-159932 |
SARS-CoV-2 Mpro-IN-30 |
Inhibitor |
/ |
Unkown |
| HY-159933 |
SARS-CoV-2-IN-105 |
Inhibitor |
/ |
Unkown |
| HY-159961 |
SARS-CoV-2 Mpro-IN-34 |
Inhibitor |
/ |
Unkown |
| HY-159985 |
Jun13728 |
Inhibitor |
/ |
Unkown |
| HY-160943 |
F594-1001 |
Inhibitor |
/ |
Unkown |
| HY-160943A |
F594-1001 hydrochloride |
Inhibitor |
/ |
Unkown |
| HY-161068 |
hACE2/SP-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-161070 |
Antiviral agent 46 |
Inhibitor |
/ |
Unkown |
| HY-161114 |
MDOLL-0229 |
Inhibitor |
/ |
Unkown |
| HY-161729 |
PLpro-IN-3 |
Inhibitor |
/ |
Unkown |
| HY-161777 |
SARS-CoV-2 Mpro-IN-23 |
Inhibitor |
/ |
Unkown |
| HY-161789 |
PROTAC SARS-CoV-2 Mpro degrader-3 |
Inhibitor |
/ |
Unkown |
| HY-161792 |
N3-C5-O-C-Boc |
|
/ |
Unkown |
| HY-161837 |
SARS-CoV-2 Mpro-IN-24 |
Inhibitor |
/ |
Unkown |
| HY-162111 |
SARS-CoV-2-IN-73 |
Inhibitor |
/ |
Unkown |
| HY-162550 |
Jobosic acid |
Inhibitor |
/ |
Unkown |
| HY-162598 |
CET-1 |
Inhibitor |
/ |
Unkown |
| HY-162604 |
SARS-CoV-2-IN-90 |
Inhibitor |
/ |
Unkown |
| HY-162674 |
MERS-CoV-IN-2 |
Inhibitor |
/ |
Unkown |
| HY-162719 |
RH12 |
Inhibitor |
/ |
Unkown |
| HY-162984 |
SARS-CoV-2-IN-99 |
Inhibitor |
/ |
Unkown |
| HY-163029 |
CTSL/B-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-163067 |
SARS-CoV-2-IN-71 |
Inhibitor |
/ |
Unkown |
| HY-163186 |
SARS-CoV-2 Mpro-IN-13 |
Inhibitor |
/ |
Unkown |
| HY-163206 |
SARS-CoV-2-IN-77 |
Inhibitor |
/ |
Unkown |
| HY-163211 |
SARS-CoV-2 Mpro-IN-14 |
Inhibitor |
/ |
Unkown |
| HY-163627 |
SARS-CoV-2 Mpro-IN-19 |
Inhibitor |
/ |
Unkown |
| HY-163628 |
SARS-CoV-2 Mpro-IN-20 |
Inhibitor |
/ |
Unkown |
| HY-163713 |
SARS-CoV-2-IN-89 |
Inhibitor |
/ |
Unkown |
| HY-163783 |
CSNK2-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-163908 |
SARS-CoV-2-IN-94 |
Inhibitor |
/ |
Unkown |
| HY-163913 |
SARS-CoV-IN-5 |
Inhibitor |
/ |
Unkown |
| HY-164868 |
SARS-CoV-2-IN-106 |
Inhibitor |
/ |
Unkown |
| HY-166878S |
SAR107375E impurity 13-d8 |
|
/ |
Unkown |
| HY-166879S |
SAR107375E Impurity 14-d8 |
|
/ |
Unkown |
| HY-168456 |
RNA recruiter 1 |
|
/ |
Unkown |
| HY-168458 |
RNA recruiter-linker 1 |
|
/ |
Unkown |
| HY-168472 |
13-TP prodrug |
Inhibitor |
/ |
Unkown |
| HY-168473 |
13-TP |
Inhibitor |
/ |
Unkown |
| HY-168584 |
SARS-CoV-2-IN-102 |
Inhibitor |
/ |
Unkown |
| HY-168917 |
9-Aminominocycline |
Inhibitor |
/ |
Unkown |
| HY-169012 |
PSB-21110 |
Inhibitor |
/ |
Unkown |
| HY-169200 |
SARS-CoV-2 Mpro-IN-26 |
Inhibitor |
/ |
Unkown |
| HY-169220S |
RORγ/DHODH-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-169222S |
RORγ/DHODH-IN-2 |
Inhibitor |
/ |
Unkown |
| HY-169501 |
WIN 62577 |
|
/ |
Unkown |
| HY-169974 |
SARS-CoV-2-IN-107 |
Inhibitor |
/ |
Unkown |
| HY-169998 |
XJ5 |
Inhibitor |
/ |
Unkown |
| HY-170399 |
SARS-CoV-2 PLpro-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-170504 |
ZHAWOC25153 |
Inhibitor |
/ |
Unkown |
| HY-170545 |
SARS-CoV-2 Mpro-IN-35 |
Inhibitor |
/ |
Unkown |
| HY-170599 |
H117 |
Inhibitor |
99.27% |
Unkown |
| HY-170819 |
VK13 |
Inhibitor |
/ |
Unkown |
| HY-170886 |
SARS-CoV-2 Mpro-IN-36 |
Inhibitor |
/ |
Unkown |
| HY-170922 |
SARS-CoV-2-IN-110 |
Inhibitor |
/ |
Unkown |
| HY-171189 |
C-467929 |
Inhibitor |
/ |
Unkown |
| HY-172223 |
3-Deazaguanosine |
Inhibitor |
/ |
Unkown |
| HY-173134 |
SARS-CoV-2 RdRp-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-173148 |
TKB272 |
Inhibitor |
/ |
Unkown |
| HY-173285 |
SARS-CoV-2 Mpro-IN-38 |
Inhibitor |
/ |
Unkown |
| HY-173305 |
Mpro/PLPro-IN-2 |
Inhibitor |
/ |
Unkown |
| HY-173362 |
SARS-CoV-2 Mpro-IN-39 |
Inhibitor |
/ |
Unkown |
| HY-173421 |
(H)S(OMe)-DFR-kbt |
Inhibitor |
/ |
Unkown |
| HY-173426 |
SARS-CoV-2 Mpro-IN-40 |
Inhibitor |
/ |
Unkown |
| HY-173459 |
N-0920 |
Inhibitor |
/ |
Unkown |
| HY-173485 |
SARS-CoV-2 Mpro-IN-41 |
Inhibitor |
/ |
Unkown |
| HY-173511 |
SARS-CoV-2 nsp13-IN-7 |
Inhibitor |
/ |
Unkown |
| HY-173514 |
SARS-CoV-2 Mpro-IN-42 |
Inhibitor |
/ |
Unkown |
| HY-173575 |
SARS-CoV-2 3CLpro-IN-31 |
Inhibitor |
/ |
Unkown |
| HY-17367S5 |
Atazanavir-d24 |
|
/ |
Unkown |
| HY-174251 |
(±)-Tuaimenal A |
Inhibitor |
/ |
Unkown |
| HY-174258 |
ATPase-IN-6 |
Inhibitor |
/ |
Unkown |
| HY-17430S2 |
Amprenavir-13C6 |
Inhibitor |
/ |
Unkown |
| HY-174320 |
SARS-CoV-2-IN-112 |
Inhibitor |
/ |
Unkown |
| HY-174385 |
SARS-CoV-2-IN-114 |
Inhibitor |
/ |
Unkown |
| HY-174402 |
PLpro-IN-9 |
Inhibitor |
/ |
Unkown |
| HY-174439 |
Nsp12-IN-2 |
Inhibitor |
/ |
Unkown |
| HY-175015 |
SARS-CoV-2 Mpro-IN-46 |
Inhibitor |
/ |
Unkown |
| HY-175024 |
MC12 |
Inhibitor |
/ |
Unkown |
| HY-17517 |
Tiadinil |
Inhibitor |
99.84% |
Unkown |
| HY-175325 |
SARS-CoV-2-IN-116 |
Inhibitor |
/ |
Unkown |
| HY-175460 |
SARS-CoV-2-IN-117 |
Inhibitor |
/ |
Unkown |
| HY-175475 |
MolPort-010-778-422 |
Inhibitor |
/ |
Unkown |
| HY-175499 |
SARS-CoV-2-IN-118 |
Inhibitor |
/ |
Unkown |
| HY-175697 |
Glycosyltransferase-IN-2 |
Inhibitor |
/ |
Unkown |
| HY-175712 |
SARS-CoV-2 Mpro-IN-47 |
Inhibitor |
/ |
Unkown |
| HY-175829 |
SARS-CoV-2-IN-119 |
Inhibitor |
/ |
Unkown |
| HY-176229 |
Mpro/Cathepsin L-IN-2 |
Inhibitor |
/ |
Unkown |
| HY-176232 |
BBH-4 |
Inhibitor |
/ |
Unkown |
| HY-176280 |
SARS-CoV-2-IN-115 |
Inhibitor |
/ |
Unkown |
| HY-176414 |
SARS-CoV-2-IN-111 |
Inhibitor |
/ |
Unkown |
| HY-176440 |
BP-198 |
|
/ |
Unkown |
| HY-176441 |
E3 ligase Ligand 66 |
|
/ |
Unkown |
| HY-176442 |
SARS-CoV-2 Mpro ligand 1 |
|
/ |
Unkown |
| HY-177332 |
SLC-391 |
Inhibitor |
/ |
Unkown |
| HY-178027 |
SARS-CoV-2 nsp14-IN-6 |
Inhibitor |
/ |
Unkown |
| HY-178027A |
SARS-CoV-2 nsp14-IN-6 ammonium |
Inhibitor |
/ |
Unkown |
| HY-178188 |
TPG-20A |
Inhibitor |
/ |
Unkown |
| HY-178318 |
LRH-0003 |
Inhibitor |
/ |
Unkown |
| HY-178435 |
SARS-CoV-2 Mpro-IN-48 |
Inhibitor |
/ |
Unkown |
| HY-178439 |
SARS-CoV-2 3CLpro-IN-33 |
Inhibitor |
/ |
Unkown |
| HY-178445 |
PI3Kδ-IN-27 |
Inhibitor |
/ |
Unkown |
| HY-178480 |
SARS-CoV-2 Mpro-IN-49 |
Inhibitor |
/ |
Unkown |
| HY-178695 |
E3 Ligase Ligand-linker Conjugate 216 |
|
/ |
Unkown |
| HY-178696 |
UAWJ9-36-3 |
Inhibitor |
/ |
Unkown |
| HY-179048 |
MH44 |
Inhibitor |
/ |
Unkown |
| HY-179097 |
SARS-CoV-2 nsp14-IN-8 |
|
/ |
Unkown |
| HY-179102 |
SARS-CoV-2 Mpro-IN-51 |
Inhibitor |
/ |
Unkown |
| HY-179419 |
Glucokinase activator 10 |
Activator |
/ |
Unkown |
| HY-179612 |
SARS-CoV-2 3CLpro-IN-34 |
Inhibitor |
/ |
Unkown |
| HY-179708 |
Cbz-QFR-kbt |
Inhibitor |
/ |
Unkown |
| HY-180126 |
SARS-CoV-2 nsp14-IN-11 |
|
/ |
Unkown |
| HY-180129 |
SARS-CoV-2-IN-120 |
Inhibitor |
/ |
Unkown |
| HY-180229 |
GK730 |
Inhibitor |
/ |
Unkown |
| HY-180369 |
SIMR-2418 |
Inhibitor |
/ |
Unkown |
| HY-180387 |
UAWJ246 |
Inhibitor |
/ |
Unkown |
| HY-180458 |
SARS-CoV-2 Mpro-IN-52 |
Inhibitor |
/ |
Unkown |
| HY-180510 |
BFC220 |
Inhibitor |
/ |
Unkown |
| HY-180516 |
BFC204 |
Inhibitor |
/ |
Unkown |
| HY-180673 |
Mpro/RdRp-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-180778 |
Insecticidal agent 28 |
Inhibitor |
/ |
Unkown |
| HY-180791 |
SARS-CoV-2-IN-121 |
Inhibitor |
/ |
Unkown |
| HY-180812 |
Antibacterial agent 312 |
Inhibitor |
/ |
Unkown |
| HY-180910 |
SARS-CoV-2 Mpro-IN-53 |
Inhibitor |
/ |
Unkown |
| HY-181154 |
PROTAC SARS-CoV-2 Mpro degrader-5 |
Degrader |
/ |
Unkown |
| HY-181162 |
SARS-CoV-2 Mpro-IN-54 |
Inhibitor |
/ |
Unkown |
| HY-181165 |
SB2960 |
Inhibitor |
/ |
Unkown |
| HY-181176 |
DEMAMP |
|
/ |
Unkown |
| HY-181192 |
PROTAC SARS-CoV-2 Mpro degrader-6 |
Degrader |
/ |
Unkown |
| HY-181193 |
PROTAC SARS-CoV-2 Mpro degrader-7 |
Degrader |
/ |
Unkown |
| HY-181249 |
SARS-CoV-2 Mpro-IN-55 |
Inhibitor |
/ |
Unkown |
| HY-181262 |
SARS-CoV-2 PLpro-IN-4 |
Inhibitor |
/ |
Unkown |
| HY-181641 |
SARS-CoV-2 PLpro-IN-6 |
Inhibitor |
/ |
Unkown |
| HY-181870 |
PROTAC SARS-CoV-2 Mpro degrader-8 |
Degrader |
/ |
Unkown |
| HY-181927 |
SARS-CoV-2 PLpro-IN-7 |
Inhibitor |
/ |
Unkown |
| HY-182292 |
SARS-CoV-2 3CLpro-IN-37 |
|
/ |
Unkown |
| HY-182425 |
MI-23 |
Inhibitor |
/ |
Unkown |
| HY-182428 |
UAWJ248 |
Inhibitor |
/ |
Unkown |
| HY-182754 |
SARS-CoV-2 Mpro-IN-57 |
Inhibitor |
/ |
Unkown |
| HY-183661 |
SCHEMBL12616233 |
Inhibitor |
/ |
Unkown |
| HY-183727 |
SARS-CoV-2 Mpro-IN-59 |
Inhibitor |
/ |
Unkown |
| HY-19344S |
Lifitegrast-d4 |
|
/ |
Unkown |
| HY-19344S1 |
Lifitegrast-d6 |
|
/ |
Unkown |
| HY-19344S2 |
Lifitegrast-d4-1 |
Antagonist |
/ |
Unkown |
| HY-32717 |
DH03 |
|
/ |
Unkown |
| HY-90001S3 |
rel-Ritonavir-d6 |
|
98.66% |
Unkown |
| HY-B0157S1 |
Ketotifen-d3 |
Inhibitor |
/ |
Unkown |
| HY-B0689S1 |
Indinavir-13C4,15N |
|
/ |
Unkown |
| HY-N0886R |
Aloin B (Standard) |
Inhibitor |
/ |
Unkown |
| HY-N12384 |
(25S)-Antcin B |
Inhibitor |
/ |
Unkown |
| HY-N15268 |
Koenine |
Inhibitor |
/ |
Unkown |
| HY-N18500 |
(+)-Adlumidine |
Inhibitor |
/ |
Unkown |
| HY-N3445 |
Jaceidin triacetate |
Inhibitor |
/ |
Unkown |
| HY-P5407 |
HD5 |
Inhibitor |
/ |
Unkown |
| HY-RS20487 |
Sar1a Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS26995 |
Sar1a Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-W012531S2 |
2-Hydroxycinnamic acid-d4 |
Inhibitor |
/ |
Unkown |
| HY-W098721 |
Z-Gly-Sar-OH |
|
/ |
Unkown |
| HY-W108137 |
Boc-Gly-Sar-OH |
|
/ |
Unkown |
| HY-W140555 |
5,7-Dimethoxyphthalide |
Inhibitor |
99.97% |
Unkown |
| HY-W217676 |
SARS-CoV-2 Mpro-IN-58 |
|
/ |
Unkown |
| HY-W614623 |
(S)-ML188 |
Inhibitor |
/ |
Unkown |
| HY-W653745 |
6-Thioguanine-13C2,15N |
|
/ |
Unkown |
| HY-W653853 |
Ritonavir-13C3 |
|
/ |
Unkown |
| HY-W728005 |
Covidcil-19 |
Inhibitor |
/ |
Unkown |
| HY-W749691 |
(S)-Velpatasvir-13c,d3 |
Inhibitor |
/ |
Unkown |
| HY-W753281 |
Dexamethasone metasulfobenzoate sodium |
Inhibitor |
/ |
Unkown |